ADMA Biologics, Inc.ADMANASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P14
Within normal range
vs 3Y Ago
-1.8x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-74.73%
20242782.88%
2023105.20%
202241.68%
2021-9.72%
2020-43.40%
2019-23.51%
2018-62.15%
2017-117.79%
2016-18.76%